What intramuscular dose of cefazolin (Ancef) should be given to a child with an open fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefazolin Dosing for Pediatric Open Fractures (IM Administration)

For pediatric patients with open fractures requiring intramuscular cefazolin, administer 25-30 mg/kg IM as a single dose, not to exceed 1-2 grams depending on body weight, with the dose given as soon as possible after injury.

Weight-Based Dosing Strategy

The optimal approach uses body weight thresholds to determine fixed doses:

  • Children <25 kg: 25-30 mg/kg IM 1
  • Children 25-50 kg: 1 gram IM 2
  • Children ≥50 kg: 2 grams IM 2

This weight cutoff of 50 kg (rather than 60 kg) provides more appropriate pharmacokinetic exposures matching adult targets 2. The maximum single dose should not exceed 2 grams 1.

Timing and Administration

Antibiotics must be administered within 1 hour of emergency department presentation 3. While 100% of surveyed Level-1 Pediatric Trauma Centers have protocols mandating <1 hour administration, actual success rates vary widely (21-100%), with only 47% of centers achieving 81-100% compliance 3. The intramuscular route is specifically indicated when the child cannot tolerate oral medications or is vomiting 4.

Fracture Grade-Specific Recommendations

Gustilo-Anderson Type I and II

  • Cefazolin alone is the first-line agent 1, 3
  • Continue for 24 hours after initial injury 5
  • 88% of pediatric trauma centers use cefazolin for Type I, and 93% for Type II 3

Gustilo-Anderson Type III

  • Cefazolin PLUS gram-negative coverage (typically gentamicin) is required 1, 5
  • Continue for 48-72 hours after injury but no more than 24 hours after wound closure 5
  • Substantial variation exists among pediatric centers for Type III antibiotic selection, with minimal consensus on optimal regimens 3

Special Contamination Scenarios

Add penicillin if farm-related injury or risk of clostridial contamination 5.

Allergy Alternatives

For penicillin/cephalosporin allergies:

  • Clindamycin is the consensus alternative (93% of centers for Type I, 87% for Type II) 3
  • Avoid using cultures obtained immediately post-injury to guide prophylaxis, as initial pathogens do not correlate with infecting organisms 5

Pharmacokinetic Considerations

After IM administration, cefazolin achieves mean serum concentrations of 37 mcg/mL at 1 hour and 3 mcg/mL at 8 hours following a 500 mg dose, with a serum half-life of approximately 2 hours 6. The drug is 60-80% excreted unchanged in urine within 24 hours 6.

Critical Pitfalls to Avoid

  • Weight-based underdosing is common and increases infection risk, particularly for gram-positive organisms susceptible to cefazolin 7
  • Patients weighing 80-120 kg require 2 grams, and those >120 kg require 3 grams 7
  • Do not rely on initial wound cultures to select prophylactic antibiotics 5
  • Always obtain thorough allergy history before administration 5
  • Document exposure mechanism (farm, water contamination) to guide additional coverage 5

Transition to Oral Therapy

After clinical improvement, transition from IM to oral cephalosporin therapy is appropriate 4. The IM route serves as a bridge when oral administration is not feasible initially.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.